Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Recruiting 1Active not recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 3Ovarian Neoplasms 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Weight Cycling 1Tobacco Use Disorder 1Tobacco Use Cessation 1Substance-Related Disorders 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Motor Activity 1Mental Disorders 1Lung Neoplasms 1Insulin Resistance 1Hematopoietic and Lymphoid System Neoplasm 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Brain Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Behavior Therapy × Clear all
NCT06432985 2025-09-30

CM_TUD_Cancer

VA Office of Research and Development

Phase NA Recruiting
108 enrolled
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡